4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001415889-25-023706
Director acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Melincoff Gwen A Director | 2025-09-03 | Grant or award | +7,500 | 7,500 | I | ||
| Derivatives | |||||||
| Melincoff Gwen A Director | 2025-09-03 | Grant or award · Stock Options (Right to Buy) | +15,000 | 15,000 | D | ||
Loading xslF345X05/form4-09042025_050913.xml…